We're excited to see what further breakthroughs we can make with our ADP research in 2024. We continue the fight with the generation of cell penetrating peptides to facilitate brain drug delivery across the blood-brain barrier (BBB). We’ll also progress our exploration the use of Lyme disease Borrelia targeting nanoparticles as therapeutics. These peptides have been designed, using computational studies of the BBB, to attach to it.
|